| Year |
Citation |
Score |
| 2023 |
Johnson KC, Kilikevicius A, Hofman C, Hu J, Liu Y, Aguilar S, Graswich J, Han Y, Wang T, Westcott JM, Brekken RA, Peng L, Karagkounis G, Corey DR. Nuclear localization of Argonaute 2 is affected by cell density and may relieve repression by microRNAs. Nucleic Acids Research. PMID 38109320 DOI: 10.1093/nar/gkad1155 |
0.567 |
|
| 2023 |
Hu J, Shen X, Kheirabadi M, Streeter MD, Qian Z, Mootha VV, Corey DR. Targeting the Expanded /Fuchs' Endothelial Corneal Dystrophy CUG Repeat with Morpholino Peptide Conjugates. Acs Omega. 8: 42797-42802. PMID 38024683 DOI: 10.1021/acsomega.3c05634 |
0.611 |
|
| 2023 |
Hu J, Gong X, Fan Y, Aguilar S, Rigo F, Prakash TP, Corey DR, Mootha VV. Modulation of Gene Expression in the Eye with Antisense Oligonucleotides. Nucleic Acid Therapeutics. PMID 37917066 DOI: 10.1089/nat.2023.0044 |
0.549 |
|
| 2023 |
Johnson KC, Kilikevicius A, Hofman C, Hu J, Liu Y, Aguilar S, Graswich J, Han Y, Wang T, Westcott JM, Brekken RA, Peng L, Karagkounis G, Corey DR. Nuclear Localization of Argonaute is affected by Cell Density and May Relieve Repression by microRNAs. Biorxiv : the Preprint Server For Biology. PMID 37461596 DOI: 10.1101/2023.07.07.548119 |
0.567 |
|
| 2023 |
Hu J, Gong X, Johnson ST, Corey DR, Mootha VV. The TCF4 Trinucleotide Repeat Expansion of Fuchs' Endothelial Corneal Dystrophy: Implications for the Anterior Segment of the Eye. Investigative Ophthalmology & Visual Science. 64: 16. PMID 37204786 DOI: 10.1167/iovs.64.5.16 |
0.587 |
|
| 2023 |
Johnson KC, Johnson ST, Liu J, Chu Y, Arana C, Han Y, Wang T, Corey DR. Consequences of depleting TNRC6, AGO, and DROSHA proteins on expression of microRNAs. Rna (New York, N.Y.). PMID 37169394 DOI: 10.1261/rna.079647.123 |
0.746 |
|
| 2023 |
Johnson KC, Corey DR. RNAi in Cell Nuclei: Potential for a new layer of biological regulation and a new strategy for therapeutic discovery. Rna (New York, N.Y.). PMID 36657971 DOI: 10.1261/rna.079500.122 |
0.346 |
|
| 2022 |
Corey DR, Ulrich HD. Editorial: Critical reviews and perspectives in Nucleic Acids Research. Nucleic Acids Research. 50: 7201. PMID 35801917 DOI: 10.1093/nar/gkac598 |
0.529 |
|
| 2022 |
Kilikevicius A, Wang J, Shen X, Rigo F, Prakash TP, Napierala M, Corey DR. Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice. Rna Biology. 19: 364-372. PMID 35289725 DOI: 10.1080/15476286.2022.2043650 |
0.314 |
|
| 2022 |
Corey DR, Damha MJ, Manoharan M. Challenges and Opportunities for Nucleic Acid Therapeutics. Nucleic Acid Therapeutics. 32: 8-13. PMID 34931905 DOI: 10.1089/nat.2021.0085 |
0.584 |
|
| 2021 |
Johnson S, Chu Y, Liu J, Corey D. Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. Rna (New York, N.Y.). PMID 34108231 DOI: 10.1261/rna.078709.121 |
0.815 |
|
| 2021 |
Chu Y, Yokota S, Liu J, Johnson K, Kilikevicius A, Corey D. Argonaute Binding within Human Nuclear RNA and its Impact on Alternative Splicing. Rna (New York, N.Y.). PMID 34108230 DOI: 10.1261/rna.078707.121 |
0.807 |
|
| 2020 |
Rong Z, Gong X, Hulleman JD, Corey DR, Mootha VV. Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs' Endothelial Corneal Dystrophy. Translational Vision Science & Technology. 9: 47. PMID 32934897 DOI: 10.1167/Tvst.9.9.47 |
0.463 |
|
| 2020 |
Chu Y, Kilikevicius A, Liu J, Johnson KC, Yokota S, Corey DR. Argonaute binding within 3'-untranslated regions poorly predicts gene repression. Nucleic Acids Research. PMID 32501500 DOI: 10.1093/Nar/Gkaa478 |
0.804 |
|
| 2020 |
Chu Y, Hu J, Liang H, Kanchwala M, Xing C, Beebe W, Bowman CB, Gong X, Corey DR, Mootha VV. Analyzing pre-symptomatic tissue to gain insights into the molecular and mechanistic origins of late-onset degenerative trinucleotide repeat disease. Nucleic Acids Research. PMID 32463444 DOI: 10.1093/Nar/Gkaa422 |
0.816 |
|
| 2020 |
Shen X, Wong J, Prakash TP, Rigo F, Li Y, Napierala M, Corey DR. Progress towards drug discovery for Friedreich's Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein. Bioorganic & Medicinal Chemistry. 115472. PMID 32279920 DOI: 10.1016/J.Bmc.2020.115472 |
0.517 |
|
| 2020 |
Chau VQ, Hu J, Gong X, Hulleman JD, Ufret-Vincenty RL, Rigo F, Prakash TP, Corey DR, Mootha VV. Delivery of Antisense Oligonucleotides to the Cornea. Nucleic Acid Therapeutics. PMID 32202944 DOI: 10.1089/Nat.2019.0838 |
0.678 |
|
| 2019 |
Liu Z, Johnson ST, Zhang Z, Corey DR. Expression of TNRC6 (GW182) Proteins Is Not Necessary for Gene Silencing by Fully Complementary RNA Duplexes. Nucleic Acid Therapeutics. PMID 31670606 DOI: 10.1089/Nat.2019.0815 |
0.533 |
|
| 2019 |
Hu J, Corey DR. Limits of using oligonucleotides for allele-selective inhibition at trinucleotide repeat sequences - targeting the CAG repeat within ataxin-1. Nucleosides, Nucleotides & Nucleic Acids. 1-10. PMID 31645175 DOI: 10.1080/15257770.2019.1671592 |
0.661 |
|
| 2019 |
Rong Z, Hu J, Corey DR, Mootha VV. Quantitative Studies of Muscleblind Proteins and Their Interaction With TCF4 RNA Foci Support Involvement in the Mechanism of Fuchs' Dystrophy. Investigative Ophthalmology & Visual Science. 60: 3980-3991. PMID 31560764 DOI: 10.1167/Iovs.19-27641 |
0.686 |
|
| 2019 |
Shen X, Beasley S, Putnam J, Li Y, Prakash T, Rigo F, Napierala M, Corey D. Efficient Electroporation of Neuronal Cells Using Synthetic Oligonucleotides: Identifying Duplex RNA and Antisense Oligonucleotide Activators of Human Frataxin Expression. Rna (New York, N.Y.). PMID 31151992 DOI: 10.1261/Rna.071290.119 |
0.443 |
|
| 2019 |
Gagnon KT, Corey DR. Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs. Nucleic Acid Therapeutics. PMID 30907681 DOI: 10.1089/Nat.2018.0772 |
0.726 |
|
| 2019 |
Hu J, Shen X, Rigo F, Prakash TP, Mootha VV, Corey DR. Duplex RNAs and ss-siRNAs Block RNA Foci Associated with Fuchs' Endothelial Corneal Dystrophy. Nucleic Acid Therapeutics. PMID 30676271 DOI: 10.1089/Nat.2018.0764 |
0.696 |
|
| 2018 |
Liu J, Liu Z, Corey DR. The Requirement for GW182 Scaffolding Protein Depends on whether Argonaute is Mediating Translation, Transcription, or Splicing. Biochemistry. PMID 30086238 DOI: 10.1021/Acs.Biochem.8B00602 |
0.49 |
|
| 2018 |
Shen X, Kilikevicius A, O'Reilly D, Prakash TP, Damha MJ, Rigo F, Corey DR. Activating frataxin expression by single-stranded siRNAs targeting the GAA repeat expansion. Bioorganic & Medicinal Chemistry Letters. PMID 30076049 DOI: 10.1016/J.Bmcl.2018.07.033 |
0.642 |
|
| 2018 |
Li L, Shen X, Liu Z, Norrbom M, Prakash TP, O'Reilly D, Sharma VK, Damha MJ, Watts JK, Rigo F, Corey DR. Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded Repeat. Nucleic Acid Therapeutics. PMID 29341839 DOI: 10.1089/Nat.2017.0703 |
0.793 |
|
| 2018 |
Hu J, Rong Z, Gong X, Zhou Z, Sharma VK, Xing C, Watts JK, Corey DR, Mootha VV. Oligonucleotides Targeting TCF4 Triplet Repeat Expansion Inhibit RNA Foci and Mis-splicing in Fuchs' Dystrophy. Human Molecular Genetics. PMID 29325021 DOI: 10.1093/Hmg/Ddy018 |
0.791 |
|
| 2017 |
Shen X, Corey DR. Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. Nucleic Acids Research. PMID 29240946 DOI: 10.1093/Nar/Gkx1239 |
0.494 |
|
| 2017 |
Hicks JA, Li L, Matsui M, Chu Y, Volkov O, Johnson KC, Corey DR. Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. Cell Reports. 20: 1543-1552. PMID 28813667 DOI: 10.1016/J.Celrep.2017.07.058 |
0.833 |
|
| 2017 |
Corey DR. RNA-Mediated Gene Activation: Identifying a Candidate RNA for Preclinical Development. Advances in Experimental Medicine and Biology. 983: 161-171. PMID 28639198 DOI: 10.1007/978-981-10-4310-9_11 |
0.509 |
|
| 2017 |
Liu J, Hu J, Ludlow AT, Pham JT, Shay JW, Rothstein JD, Corey DR. c9orf72 Disease-Related Foci Are Each Composed of One Mutant Expanded Repeat RNA. Cell Chemical Biology. PMID 28132891 DOI: 10.1016/J.Chembiol.2016.12.018 |
0.696 |
|
| 2016 |
Hu J, Rigo F, Prakash TP, Corey DR. Recognition of c9orf72 Mutant RNA by Single-Stranded Silencing RNAs. Nucleic Acid Therapeutics. PMID 28005462 DOI: 10.1089/nat.2016.0655 |
0.694 |
|
| 2016 |
Corey DR. Synthetic Nucleic Acids and Treatment of Neurological Diseases. Jama Neurology. PMID 27479447 DOI: 10.1001/Jamaneurol.2016.2089 |
0.32 |
|
| 2016 |
Matsui M, Corey DR. Non-coding RNAs as drug targets. Nature Reviews. Drug Discovery. PMID 27444227 DOI: 10.1038/Nrd.2016.117 |
0.812 |
|
| 2016 |
Liu H, Liang C, Kollipara RK, Matsui M, Ke X, Jeong BC, Wang Z, Yoo KS, Yadav GP, Kinch LN, Grishin NV, Nam Y, Corey DR, Kittler R, Liu Q. HP1BP3, a Chromatin Retention Factor for Co-transcriptional MicroRNA Processing. Molecular Cell. PMID 27425409 DOI: 10.1016/J.Molcel.2016.06.014 |
0.75 |
|
| 2016 |
Kalantari R, Hicks JA, Li L, Gagnon KT, Sridhara V, Lemoff A, Mirzaei H, Corey DR. Stable association of RNAi machinery is conserved between the cytoplasm and nucleus of human cells. Rna (New York, N.Y.). PMID 27198507 DOI: 10.1261/Rna.056499.116 |
0.782 |
|
| 2016 |
Matsui M, Prakash TP, Corey DR. Argonaute 2-dependent Regulation of Gene Expression by Single-stranded miRNA Mimics. Molecular Therapy : the Journal of the American Society of Gene Therapy. 24: 946-55. PMID 26903376 DOI: 10.1038/Mt.2016.39 |
0.771 |
|
| 2016 |
Dodd DW, Tomchick DR, Corey DR, Gagnon KT. Pathogenic C9ORF72 Antisense Repeat RNA Forms a Double Helix with Tandem C:C Mismatches. Biochemistry. PMID 26878348 DOI: 10.1021/Acs.Biochem.6B00136 |
0.739 |
|
| 2016 |
Matsui M, Threlfall RN, Caruthers MH, Corey DR. Effect of 2'-O-methyl/thiophosphonoacetate-modified antisense oligonucleotides on huntingtin expression in patient-derived cells. Artificial Dna, Pna & Xna. 0. PMID 26865404 DOI: 10.1080/1949095X.2016.1146391 |
0.785 |
|
| 2016 |
Li L, Matsui M, Corey DR. Activating frataxin expression by repeat-targeted nucleic acids. Nature Communications. 7: 10606. PMID 26842135 DOI: 10.1038/Ncomms10606 |
0.847 |
|
| 2016 |
Kalantari R, Chiang CM, Corey DR. Regulation of mammalian transcription and splicing by Nuclear RNAi. Nucleic Acids Research. 44: 524-37. PMID 26612865 DOI: 10.1093/Nar/Gkv1305 |
0.837 |
|
| 2016 |
Corey D. Abstract IA23: Targeting nuclear noncoding RNAs Cancer Research. 76. DOI: 10.1158/1538-7445.Nonrna15-Ia23 |
0.52 |
|
| 2015 |
Gagnon KT, Corey DR. Stepping toward therapeutic CRISPR. Proceedings of the National Academy of Sciences of the United States of America. PMID 26644585 DOI: 10.1073/Pnas.1521670112 |
0.715 |
|
| 2015 |
Hu J, Liu J, Li L, Gagnon KT, Corey DR. Engineering Duplex RNAs for Challenging Targets: Recognition of GGGGCC/CCCCGG Repeats at the ALS/FTD C9orf72 Locus. Chemistry & Biology. PMID 26584779 DOI: 10.1016/J.Chembiol.2015.09.016 |
0.846 |
|
| 2015 |
Matsui M, Li L, Janowski BA, Corey DR. Reduced Expression of Argonaute 1, Argonaute 2, and TRBP Changes Levels and Intracellular Distribution of RNAi Factors. Scientific Reports. 5: 12855. PMID 26242502 DOI: 10.1038/Srep12855 |
0.808 |
|
| 2015 |
Wang T, Xiao G, Chu Y, Zhang MQ, Corey DR, Xie Y. Design and bioinformatics analysis of genome-wide CLIP experiments. Nucleic Acids Research. 43: 5263-74. PMID 25958398 DOI: 10.1093/Nar/Gkv439 |
0.796 |
|
| 2015 |
Chu Y, Wang T, Dodd D, Xie Y, Janowski BA, Corey DR. Intramolecular circularization increases efficiency of RNA sequencing and enables CLIP-Seq of nuclear RNA from human cells. Nucleic Acids Research. 43: e75. PMID 25813040 DOI: 10.1093/Nar/Gkv213 |
0.816 |
|
| 2015 |
Liu J, Hu J, Hicks JA, Prakash TP, Corey DR. Modulation of Splicing by Single-Stranded Silencing RNAs. Nucleic Acid Therapeutics. 25: 113-20. PMID 25757055 DOI: 10.1089/Nat.2014.0527 |
0.806 |
|
| 2015 |
Younger ST, Corey DR. Identification and validation of miRNA target sites within nontraditional miRNA targets. Methods in Molecular Biology (Clifton, N.J.). 1206: 53-67. PMID 25240886 DOI: 10.1007/978-1-4939-1369-5_5 |
0.749 |
|
| 2014 |
Gagnon KT, Li L, Janowski BA, Corey DR. Analysis of nuclear RNA interference in human cells by subcellular fractionation and Argonaute loading. Nature Protocols. 9: 2045-60. PMID 25079428 DOI: 10.1038/Nprot.2014.135 |
0.773 |
|
| 2014 |
Hu J, Liu J, Narayanannair KJ, Lackey JG, Kuchimanchi S, Rajeev KG, Manoharan M, Swayze EE, Lima WF, Prakash TP, Xiang Q, Martinez C, Corey DR. Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs. Biochemistry. 53: 4510-8. PMID 24981774 DOI: 10.1021/Bi500610R |
0.728 |
|
| 2014 |
Hu J, Liu J, Yu D, Aiba Y, Lee S, Pendergraff H, Boubaker J, Artates JW, Lagier-Tourenne C, Lima WF, Swayze EE, Prakash TP, Corey DR. Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs. Nucleic Acid Therapeutics. 24: 199-209. PMID 24694346 DOI: 10.1089/Nat.2013.0476 |
0.83 |
|
| 2014 |
Gagnon KT, Li L, Chu Y, Janowski BA, Corey DR. RNAi factors are present and active in human cell nuclei. Cell Reports. 6: 211-21. PMID 24388755 DOI: 10.1016/J.Celrep.2013.12.013 |
0.827 |
|
| 2013 |
Aiba Y, Hu J, Liu J, Xiang Q, Martinez C, Corey DR. Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions. Biochemistry. 52: 9329-38. PMID 24266403 DOI: 10.1021/Bi4014209 |
0.835 |
|
| 2013 |
Matsui M, Chu Y, Zhang H, Gagnon KT, Shaikh S, Kuchimanchi S, Manoharan M, Corey DR, Janowski BA. Promoter RNA links transcriptional regulation of inflammatory pathway genes. Nucleic Acids Research. 41: 10086-109. PMID 23999091 DOI: 10.1093/Nar/Gkt777 |
0.835 |
|
| 2013 |
Liu J, Yu D, Aiba Y, Pendergraff H, Swayze EE, Lima WF, Hu J, Prakash TP, Corey DR. ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy. Nucleic Acids Research. 41: 9570-83. PMID 23935115 DOI: 10.1093/Nar/Gkt693 |
0.838 |
|
| 2013 |
Liu J, Pendergraff H, Narayanannair KJ, Lackey JG, Kuchimanchi S, Rajeev KG, Manoharan M, Hu J, Corey DR. RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression. Nucleic Acids Research. 41: 8788-801. PMID 23887934 DOI: 10.1093/Nar/Gkt594 |
0.736 |
|
| 2013 |
Dodd DW, Gagnon KT, Corey DR. Digital quantitation of potential therapeutic target RNAs. Nucleic Acid Therapeutics. 23: 188-94. PMID 23656494 DOI: 10.1089/Nat.2013.0427 |
0.757 |
|
| 2013 |
Matsui M, Prakash TP, Corey DR. Transcriptional silencing by single-stranded RNAs targeting a noncoding RNA that overlaps a gene promoter. Acs Chemical Biology. 8: 122-6. PMID 23082936 DOI: 10.1021/Cb300490J |
0.829 |
|
| 2013 |
Corey DR, Dimmeler S, Kornfeld J. Targeting Noncoding RNAs in Disease: Challenges and Opportunities Science. 341: 1021.3-1021. DOI: 10.1126/Science.341.6149.1021-C |
0.488 |
|
| 2012 |
Hu J, Liu J, Yu D, Chu Y, Corey DR. Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway. Nucleic Acids Research. 40: 11270-80. PMID 23042244 DOI: 10.1093/Nar/Gks907 |
0.836 |
|
| 2012 |
Yu D, Pendergraff H, Liu J, Kordasiewicz HB, Cleveland DW, Swayze EE, Lima WF, Crooke ST, Prakash TP, Corey DR. Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell. 150: 895-908. PMID 22939619 DOI: 10.1016/J.Cell.2012.08.002 |
0.519 |
|
| 2012 |
Chu Y, Corey DR. RNA sequencing: platform selection, experimental design, and data interpretation. Nucleic Acid Therapeutics. 22: 271-4. PMID 22830413 DOI: 10.1089/Nat.2012.0367 |
0.795 |
|
| 2012 |
Chu Y, Kalantari R, Dodd DW, Corey DR. Transcriptional silencing by hairpin RNAs complementary to a gene promoter. Nucleic Acid Therapeutics. 22: 147-51. PMID 22703280 DOI: 10.1089/Nat.2012.0360 |
0.84 |
|
| 2012 |
Matsui M, Corey DR. Allele-selective inhibition of trinucleotide repeat genes. Drug Discovery Today. 17: 443-50. PMID 22285529 DOI: 10.1016/J.Drudis.2012.01.006 |
0.773 |
|
| 2012 |
Gagnon KT, Corey DR. Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression. Nucleic Acid Therapeutics. 22: 3-16. PMID 22283730 DOI: 10.1089/Nat.2011.0330 |
0.778 |
|
| 2012 |
Watts JK, Corey DR. Silencing disease genes in the laboratory and the clinic. The Journal of Pathology. 226: 365-79. PMID 22069063 DOI: 10.1002/Path.2993 |
0.642 |
|
| 2012 |
Liu J, Hu J, Corey DR. Expanding the action of duplex RNAs into the nucleus: redirecting alternative splicing. Nucleic Acids Research. 40: 1240-50. PMID 21948593 DOI: 10.1093/Nar/Gkr780 |
0.74 |
|
| 2012 |
Corey D. Non-coding RNAs and cancer: An AACR special conference, Miami, FL, USA, January 8-11, 2012 Drugs of the Future. 37: 297. DOI: 10.1358/Dof.2012.037.04.1784682 |
0.369 |
|
| 2012 |
Corey D. Abstract IA11: Control of gene expression in the nucleus by small RNAs Cancer Research. 72: IA11-IA11. DOI: 10.1158/1538-7445.Nonrna12-Ia11 |
0.558 |
|
| 2011 |
Yu D, Sakurai F, Corey DR. Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. Bioorganic & Medicinal Chemistry Letters. 21: 5202-5. PMID 21840716 DOI: 10.1016/J.Bmcl.2011.07.053 |
0.342 |
|
| 2011 |
Peña-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, Wolff NC, Tran TA, Zou L, Xie XJ, Corey DR, Brugarolas J. Regulation of TFEB and V-ATPases by mTORC1. The Embo Journal. 30: 3242-58. PMID 21804531 DOI: 10.1038/Emboj.2011.257 |
0.687 |
|
| 2011 |
Schwartz JC, Corey DR. Practical considerations for analyzing antigene RNAs (agRNAs): RNA immunoprecipitation of argonaute protein. Methods in Molecular Biology (Clifton, N.J.). 764: 301-15. PMID 21748649 DOI: 10.1007/978-1-61779-188-8_20 |
0.769 |
|
| 2011 |
Younger ST, Corey DR. Transcriptional regulation by miRNA mimics that target sequences downstream of gene termini. Molecular Biosystems. 7: 2383-8. PMID 21589992 DOI: 10.1039/C1Mb05090G |
0.794 |
|
| 2011 |
Gagnon KT, Watts JK, Pendergraff HM, Montaillier C, Thai D, Potier P, Corey DR. Antisense and antigene inhibition of gene expression by cell-permeable oligonucleotide-oligospermine conjugates. Journal of the American Chemical Society. 133: 8404-7. PMID 21539318 DOI: 10.1021/Ja200312Y |
0.796 |
|
| 2011 |
Younger ST, Corey DR. Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Research. 39: 5682-91. PMID 21427083 DOI: 10.1093/Nar/Gkr155 |
0.766 |
|
| 2011 |
Hu J, Gagnon KT, Liu J, Watts JK, Syeda-Nawaz J, Bennett CF, Swayze EE, Randolph J, Chattopadhyaya J, Corey DR. Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs. Biological Chemistry. 392: 315-25. PMID 21294677 DOI: 10.1515/Bc.2011.045 |
0.829 |
|
| 2010 |
Matsui M, Sakurai F, Elbashir S, Foster DJ, Manoharan M, Corey DR. Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter. Chemistry & Biology. 17: 1344-55. PMID 21168770 DOI: 10.1016/J.Chembiol.2010.10.009 |
0.819 |
|
| 2010 |
Hu J, Liu J, Corey DR. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism. Chemistry & Biology. 17: 1183-8. PMID 21095568 DOI: 10.1016/J.Chembiol.2010.10.013 |
0.702 |
|
| 2010 |
Gagnon KT, Pendergraff HM, Deleavey GF, Swayze EE, Potier P, Randolph J, Roesch EB, Chattopadhyaya J, Damha MJ, Bennett CF, Montaillier C, Lemaitre M, Corey DR. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry. 49: 10166-78. PMID 21028906 DOI: 10.1021/Bi101208K |
0.782 |
|
| 2010 |
Chu Y, Yue X, Younger ST, Janowski BA, Corey DR. Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Research. 38: 7736-48. PMID 20675357 DOI: 10.1093/Nar/Gkq648 |
0.83 |
|
| 2010 |
Janowski BA, Corey DR. Minireview: Switching on progesterone receptor expression with duplex RNA. Molecular Endocrinology (Baltimore, Md.). 24: 2243-52. PMID 20592161 DOI: 10.1210/Me.2010-0067 |
0.536 |
|
| 2010 |
Yue X, Schwartz JC, Chu Y, Younger ST, Gagnon KT, Elbashir S, Janowski BA, Corey DR. Transcriptional regulation by small RNAs at sequences downstream from 3' gene termini. Nature Chemical Biology. 6: 621-9. PMID 20581822 DOI: 10.1038/Nchembio.400 |
0.832 |
|
| 2010 |
Wancewicz EV, Maier MA, Siwkowski AM, Albertshofer K, Winger TM, Berdeja A, Gaus H, Vickers TA, Bennett CF, Monia BP, Griffey RH, Nulf CJ, Hu J, Corey DR, Swayze EE, et al. Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissue. Journal of Medicinal Chemistry. 53: 3919-26. PMID 20420385 DOI: 10.1021/Jm901489K |
0.625 |
|
| 2010 |
Watts JK, Yu D, Charisse K, Montaillier C, Potier P, Manoharan M, Corey DR. Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters. Nucleic Acids Research. 38: 5242-59. PMID 20403811 DOI: 10.1093/Nar/Gkq258 |
0.727 |
|
| 2010 |
Watts JK, Corey DR. Clinical status of duplex RNA. Bioorganic & Medicinal Chemistry Letters. 20: 3203-7. PMID 20399650 DOI: 10.1016/J.Bmcl.2010.03.109 |
0.699 |
|
| 2009 |
Hu J, Matsui M, Corey DR. Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA. Annals of the New York Academy of Sciences. 1175: 24-31. PMID 19796074 DOI: 10.1111/J.1749-6632.2009.04975.X |
0.836 |
|
| 2009 |
Hu J, Dodd DW, Hudson RH, Corey DR. Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy)phenyl]pyrrolocytosine. Bioorganic & Medicinal Chemistry Letters. 19: 6181-4. PMID 19783436 DOI: 10.1016/J.Bmcl.2009.09.004 |
0.659 |
|
| 2009 |
Younger ST, Pertsemlidis A, Corey DR. Predicting potential miRNA target sites within gene promoters. Bioorganic & Medicinal Chemistry Letters. 19: 3791-4. PMID 19423343 DOI: 10.1016/J.Bmcl.2009.04.032 |
0.779 |
|
| 2009 |
Hu J, Matsui M, Gagnon KT, Schwartz JC, Gabillet S, Arar K, Wu J, Bezprozvanny I, Corey DR. Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Nature Biotechnology. 27: 478-84. PMID 19412185 DOI: 10.1038/Nbt.1539 |
0.827 |
|
| 2009 |
Younger ST, Corey DR. The puzzle of RNAs that target gene promoters. Chembiochem : a European Journal of Chemical Biology. 10: 1135-9. PMID 19301312 DOI: 10.1002/Cbic.200900015 |
0.796 |
|
| 2009 |
Corey D. Handbook of RNA Biochemistry: Student Edition. Edited by Roland Karl Hartmann and Albrecht Bindereif, Astrid Schön and Eric Westhof. Chembiochem. 10: 1568-1568. DOI: 10.1002/Cbic.200900256 |
0.374 |
|
| 2008 |
Beane R, Gabillet S, Montaillier C, Arar K, Corey DR. Recognition of chromosomal DNA inside cells by locked nucleic acids. Biochemistry. 47: 13147-9. PMID 19053275 DOI: 10.1021/Bi801930P |
0.824 |
|
| 2008 |
Schwartz JC, Younger ST, Nguyen NB, Hardy DB, Monia BP, Corey DR, Janowski BA. Antisense transcripts are targets for activating small RNAs. Nature Structural & Molecular Biology. 15: 842-8. PMID 18604220 DOI: 10.1038/Nsmb.1444 |
0.847 |
|
| 2007 |
Corey DR. Chemical modification: the key to clinical application of RNA interference? The Journal of Clinical Investigation. 117: 3615-22. PMID 18060019 DOI: 10.1172/Jci33483 |
0.482 |
|
| 2007 |
Hu J, Corey DR. Inhibiting gene expression with peptide nucleic acid (PNA)--peptide conjugates that target chromosomal DNA. Biochemistry. 46: 7581-9. PMID 17536840 DOI: 10.1021/Bi700230A |
0.668 |
|
| 2007 |
Beane RL, Ram R, Gabillet S, Arar K, Monia BP, Corey DR. Inhibiting gene expression with locked nucleic acids (LNAs) that target chromosomal DNA. Biochemistry. 46: 7572-80. PMID 17536839 DOI: 10.1021/Bi700227G |
0.806 |
|
| 2007 |
Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nature Chemical Biology. 3: 166-73. PMID 17259978 DOI: 10.1038/Nchembio860 |
0.853 |
|
| 2007 |
Corey DR. RNA learns from antisense. Nature Chemical Biology. 3: 8-11. PMID 17173018 DOI: 10.1038/Nchembio0107-8 |
0.421 |
|
| 2006 |
Janowski BA, Hu J, Corey DR. Silencing gene expression by targeting chromosomal DNA with antigene peptide nucleic acids and duplex RNAs. Nature Protocols. 1: 436-43. PMID 17406266 DOI: 10.1038/Nprot.2006.64 |
0.71 |
|
| 2006 |
Johnson AA, Sayer JM, Yagi H, Patil SS, Debart F, Maier MA, Corey DR, Vasseur JJ, Burke TR, Marquez VE, Jerina DM, Pommier Y. Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site. The Journal of Biological Chemistry. 281: 32428-38. PMID 16943199 DOI: 10.1074/Jbc.M605101200 |
0.316 |
|
| 2006 |
Janowski BA, Huffman KE, Schwartz JC, Ram R, Nordsell R, Shames DS, Minna JD, Corey DR. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nature Structural & Molecular Biology. 13: 787-92. PMID 16936728 DOI: 10.1038/Nsmb1140 |
0.849 |
|
| 2006 |
Hardy DB, Janowski BA, Corey DR, Mendelson CR. Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Molecular Endocrinology (Baltimore, Md.). 20: 2724-33. PMID 16772530 DOI: 10.1210/Me.2006-0112 |
0.358 |
|
| 2006 |
Canales BK, Li Y, Thompson MG, Gleason JM, Chen Z, Malaeb B, Corey DR, Herbert BS, Shay JW, Koeneman KS. Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer model. Urologic Oncology. 24: 141-51. PMID 16520278 DOI: 10.1016/J.Urolonc.2005.11.003 |
0.301 |
|
| 2005 |
Janowski BA, Corey DR. Inhibiting transcription of chromosomal DNA using antigene RNAs. Nucleic Acids Symposium Series (2004). 367-8. PMID 17150786 DOI: 10.1093/nass/49.1.367 |
0.423 |
|
| 2005 |
Janowski BA, Huffman KE, Schwartz JC, Ram R, Hardy D, Shames DS, Minna JD, Corey DR. Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nature Chemical Biology. 1: 216-22. PMID 16408038 DOI: 10.1038/Nchembio725 |
0.845 |
|
| 2005 |
Janowski BA, Kaihatsu K, Huffman KE, Schwartz JC, Ram R, Hardy D, Mendelson CR, Corey DR. Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids. Nature Chemical Biology. 1: 210-5. PMID 16408037 DOI: 10.1038/Nchembio724 |
0.82 |
|
| 2005 |
Corey DR. Recognition of chromosomal DNA in human cells by peptide nucleic acids and small duplex RNAs. Annals of the New York Academy of Sciences. 1058: 16-25. PMID 16394122 DOI: 10.1196/Annals.1359.003 |
0.571 |
|
| 2005 |
Corey DR. Regulating mammalian transcription with RNA. Trends in Biochemical Sciences. 30: 655-8. PMID 16226463 DOI: 10.1016/J.Tibs.2005.09.007 |
0.517 |
|
| 2005 |
Corey DR. Calcium liberates PNAs from endosomes. Chemistry & Biology. 12: 864-5. PMID 16125097 DOI: 10.1016/J.Chembiol.2005.08.003 |
0.357 |
|
| 2005 |
Huffman KE, Corey DR. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. Biochemistry. 44: 2253-61. PMID 15709737 DOI: 10.1021/Bi047948G |
0.638 |
|
| 2005 |
Corey DR. Peptide nucleic acids: Cellular delivery and recognition of DNA and RNA targets International Journal of Peptide Research and Therapeutics. 10: 347-352. DOI: 10.1007/s10989-005-4902-9 |
0.368 |
|
| 2004 |
Natarajan S, Chen Z, Wancewicz EV, Monia BP, Corey DR. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity. Oligonucleotides. 14: 263-73. PMID 15665594 DOI: 10.1089/Oli.2004.14.263 |
0.482 |
|
| 2004 |
Kaihatsu K, Huffman KE, Corey DR. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates. Biochemistry. 43: 14340-7. PMID 15533038 DOI: 10.1021/Bi048519L |
0.805 |
|
| 2004 |
Paroo Z, Bollinger RA, Braasch DA, Richer E, Corey DR, Antich PP, Mason RP. Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Molecular Imaging. 3: 117-24. PMID 15296676 DOI: 10.1162/1535350041464865 |
0.712 |
|
| 2004 |
Paroo Z, Corey DR. Challenges for RNAi in vivo. Trends in Biotechnology. 22: 390-4. PMID 15283982 DOI: 10.1016/J.Tibtech.2004.06.004 |
0.425 |
|
| 2004 |
Nulf CJ, Corey D. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs). Nucleic Acids Research. 32: 3792-8. PMID 15263060 DOI: 10.1093/Nar/Gkh706 |
0.348 |
|
| 2004 |
Kaihatsu K, Janowski BA, Corey DR. Recognition of chromosomal DNA by PNAs. Chemistry & Biology. 11: 749-58. PMID 15217608 DOI: 10.1016/J.Chembiol.2003.09.014 |
0.772 |
|
| 2004 |
Kaihatsu K, Corey DR. Synthesis of peptide nucleic acid-peptide conjugates. Methods in Molecular Biology (Clifton, N.J.). 283: 207-14. PMID 15197312 DOI: 10.1385/1-59259-813-7:207 |
0.718 |
|
| 2004 |
Corey DR. Synthesis of oligonucleotide-peptide and oligonucleotide-protein conjugates. Methods in Molecular Biology (Clifton, N.J.). 283: 197-206. PMID 15197311 DOI: 10.1385/1-59259-813-7:197 |
0.363 |
|
| 2004 |
Braasch DA, Paroo Z, Constantinescu A, Ren G, Oz OK, Mason RP, Corey DR. Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorganic & Medicinal Chemistry Letters. 14: 1139-43. PMID 14980652 DOI: 10.1016/J.Bmcl.2003.12.074 |
0.803 |
|
| 2004 |
Liu Y, Braasch DA, Nulf CJ, Corey DR. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids. Biochemistry. 43: 1921-7. PMID 14967032 DOI: 10.1021/Bi0358519 |
0.789 |
|
| 2003 |
Kaihatsu K, Shah RH, Zhao X, Corey DR. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates. Biochemistry. 42: 13996-4003. PMID 14636068 DOI: 10.1021/Bi035194K |
0.758 |
|
| 2003 |
Liu B, Han Y, Ferdous A, Corey DR, Kodadek T. Transcription activation by a PNA-peptide chimera in a mammalian cell extract. Chemistry & Biology. 10: 909-16. PMID 14583257 DOI: 10.1016/J.Chembiol.2003.09.008 |
0.428 |
|
| 2003 |
Zhao X, Kaihatsu K, Corey DR. Inhibition of transcription by bisPNA-peptide conjugates. Nucleosides, Nucleotides & Nucleic Acids. 22: 535-46. PMID 14565228 DOI: 10.1081/Ncn-120021953 |
0.748 |
|
| 2003 |
Paroo Z, Corey DR. Imaging gene expression using oligonucleotides and peptide nucleic acids. Journal of Cellular Biochemistry. 90: 437-42. PMID 14523977 DOI: 10.1002/Jcb.10626 |
0.353 |
|
| 2003 |
Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, White MA, Corey DR. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry. 42: 7967-75. PMID 12834349 DOI: 10.1021/Bi0343774 |
0.824 |
|
| 2003 |
Bergstrom RC, Coombs GS, Ye S, Madison EL, Goldsmith EJ, Corey DR. Binding of nonphysiological protein and peptide substrates to proteases: differences between urokinase-type plasminogen activator and trypsin and contributions to the evolution of regulated proteolysis. Biochemistry. 42: 5395-402. PMID 12731881 DOI: 10.1021/Bi027417X |
0.735 |
|
| 2003 |
Barma DK, Elayadi A, Falck JR, Corey DR. Inhibition of telomerase by BIBR 1532 and related analogues. Bioorganic & Medicinal Chemistry Letters. 13: 1333-6. PMID 12657276 DOI: 10.1016/S0960-894X(03)00101-X |
0.78 |
|
| 2003 |
Chen Z, Corey DR. Telomerase inhibitors: a new option for chemotherapy. Advances in Cancer Research. 87: 31-58. PMID 12641273 DOI: 10.1016/S0065-230X(03)87173-7 |
0.315 |
|
| 2003 |
Gamper HB, Nulf CJ, Corey DR, Kmiec EB. The synaptic complex of RecA protein participates in hybridization and inverse strand exchange reactions. Biochemistry. 42: 2643-55. PMID 12614159 DOI: 10.1021/Bi0205202 |
0.329 |
|
| 2003 |
Corey DR. Peptide nucleic acids: Cellular delivery and recognition of DNA and RNA targets International Journal of Peptide Research and Therapeutics. 10: 347-352. DOI: 10.1007/S10989-004-4902-1 |
0.473 |
|
| 2003 |
Corey DR. Peptide nucleic acids: Cellular delivery and recognition of DNA and RNA targets Letters in Peptide Science. 10: 347-352. DOI: 10.1007/BF02484569 |
0.349 |
|
| 2002 |
Braasch DA, Corey DR. Cellular delivery of locked nucleic acids (LNAs). Current Protocols in Nucleic Acid Chemistry / Edited by Serge L. Beaucage ... [Et Al.]. Unit 4.13. PMID 18428895 DOI: 10.1002/0471142700.Nc0413S09 |
0.794 |
|
| 2002 |
Braasch DA, Nulf CJ, Corey DR. Synthesis and purification of peptide nucleic acids. Current Protocols in Nucleic Acid Chemistry / Edited by Serge L. Beaucage ... [Et Al.]. Unit 4.11. PMID 18428893 DOI: 10.1002/0471142700.Nc0411S09 |
0.778 |
|
| 2002 |
Yegorov YE, Kazimirchuk EV, Terekhov SM, Karachentsev DN, Shirokova EA, Khandazhinskaya AL, Meshcheryakova JA, Corey DR, Zelenin AV. Telomerase-dependent reactivation of DNA synthesis in macrophages implies alteration of telomeres. Cell Biology International. 26: 1019-27. PMID 12468377 DOI: 10.1006/Cbir.2002.0961 |
0.398 |
|
| 2002 |
Braasch DA, Liu Y, Corey DR. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Research. 30: 5160-7. PMID 12466540 DOI: 10.1093/Nar/Gkf651 |
0.799 |
|
| 2002 |
Chen Z, Monia BP, Corey DR. Telomerase inhibition, telomere shortening, and decreased cell proliferation by cell permeable 2'-O-methoxyethyl oligonucleotides. Journal of Medicinal Chemistry. 45: 5423-5. PMID 12459009 DOI: 10.1021/Jm025563V |
0.379 |
|
| 2002 |
Braasch DA, Corey DR. Lipid-mediated introduction of peptide nucleic acids into cells. Methods in Molecular Biology (Clifton, N.J.). 208: 211-23. PMID 12229290 DOI: 10.1385/1-59259-290-2:211 |
0.748 |
|
| 2002 |
Kaihatsu K, Braasch DA, Cansizoglu A, Corey DR. Enhanced strand invasion by peptide nucleic acid-peptide conjugates. Biochemistry. 41: 11118-25. PMID 12220176 DOI: 10.1021/Bi0263659 |
0.808 |
|
| 2002 |
Elayadi AN, Braasch DA, Corey DR. Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase. Biochemistry. 41: 9973-81. PMID 12146961 DOI: 10.1021/Bi025907J |
0.823 |
|
| 2002 |
Lee HJ, Boado RJ, Braasch DA, Corey DR, Pardridge WM. Imaging gene expression in the brain in vivo in a transgenic mouse model of Huntington's disease with an antisense radiopharmaceutical and drug-targeting technology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 948-56. PMID 12097468 |
0.749 |
|
| 2002 |
Nulf CJ, Corey DR. DNA assembly using bis-peptide nucleic acids (bisPNAs). Nucleic Acids Research. 30: 2782-9. PMID 12087161 DOI: 10.1093/Nar/Gkf389 |
0.349 |
|
| 2002 |
Braasch DA, Corey DR. Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry. 41: 4503-10. PMID 11926811 DOI: 10.1021/Bi0122112 |
0.778 |
|
| 2002 |
Liu B, Han Y, Corey DR, Kodadek T. Toward synthetic transcription activators: recruitment of transcription factors to DNA by a PNA-peptide chimera. Journal of the American Chemical Society. 124: 1838-9. PMID 11866581 DOI: 10.1021/Ja0164226 |
0.379 |
|
| 2002 |
Tackett AJ, Corey DR, Raney KD. Non-Watson-Crick interactions between PNA and DNA inhibit the ATPase activity of bacteriophage T4 Dda helicase. Nucleic Acids Research. 30: 950-7. PMID 11842106 DOI: 10.1093/Nar/30.4.950 |
0.381 |
|
| 2001 |
Doyle DF, Braasch DA, Jackson LK, Weiss HE, Boehm MF, Mangelsdorf DJ, Corey DR. Engineering orthogonal ligand-receptor pairs from "near drugs". Journal of the American Chemical Society. 123: 11367-71. PMID 11707111 DOI: 10.1021/Ja0164632 |
0.771 |
|
| 2001 |
Elayadi AN, Corey DR. Application of PNA and LNA oligomers to chemotherapy. Current Opinion in Investigational Drugs (London, England : 2000). 2: 558-61. PMID 11566018 |
0.793 |
|
| 2001 |
Zhang X, Simmons CG, Corey DR. Liver cell specific targeting of peptide nucleic acid oligomers Bioorganic and Medicinal Chemistry Letters. 11: 1269-1272. PMID 11392534 DOI: 10.1016/S0960-894X(01)00198-6 |
0.367 |
|
| 2001 |
Corey DR, Abrams JM. Morpholino antisense oligonucleotides: Tools for investigating vertebrate development Genome Biology. 2. PMID 11387041 DOI: 10.1186/Gb-2001-2-5-Reviews1015 |
0.348 |
|
| 2001 |
Elayadi AN, Demieville A, Wancewicz EV, Monia BP, Corey DR. Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells. Nucleic Acids Research. 29: 1683-9. PMID 11292840 DOI: 10.1093/Nar/29.8.1683 |
0.825 |
|
| 2001 |
Bergstrom RC, Mayfield LD, Corey DR. A bridge between the RNA and protein worlds? Accelerating delivery of chemical reactivity to RNA and DNA by a specific short peptide (AAKK)(4). Chemistry & Biology. 8: 199-205. PMID 11251293 DOI: 10.1016/S1074-5521(01)00004-7 |
0.483 |
|
| 2001 |
Braasch DA, Corey DR. Locked nucleic acid (LNA): Fine-tuning the recognition of DNA and RNA Chemistry and Biology. 8: 1-7. PMID 11182314 DOI: 10.1016/S1074-5521(00)00058-2 |
0.802 |
|
| 2001 |
Braasch DA, Corey DR. Synthesis, analysis, purification, and intracellular delivery of peptide nucleic acids Methods. 23: 97-107. PMID 11181029 DOI: 10.1006/Meth.2000.1111 |
0.768 |
|
| 2001 |
Doyle DF, Braasch DA, Simmons CG, Janowski BA, Corey DR. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry. 40: 53-64. PMID 11141056 DOI: 10.1021/Bi0020630 |
0.838 |
|
| 2000 |
Zhang X, Ishihara T, Corey DR. Strand invasion by mixed base PNAs and a PNA-peptide chimera. Nucleic Acids Research. 28: 3332-8. PMID 10954602 DOI: 10.1093/Nar/28.17.3332 |
0.711 |
|
| 2000 |
Hervio LS, Coombs GS, Bergstrom RC, Trivedi K, Corey DR, Madison EL. Negative selectivity and the evolution of protease cascades: the specificity of plasmin for peptide and protein substrates. Chemistry & Biology. 7: 443-53. PMID 10873836 DOI: 10.1016/S1074-5521(00)00125-3 |
0.736 |
|
| 2000 |
Doyle DF, Mangelsdorf DJ, Corey DR. Modifying ligand specificity of gene regulatory proteins. Current Opinion in Chemical Biology. 4: 60-3. PMID 10679376 DOI: 10.1016/S1367-5931(99)00052-6 |
0.618 |
|
| 1999 |
Ishihara T, Corey DR. Strand invasion by DNA-peptide conjugates and peptide nucleic acids. Nucleic Acids Symposium Series. 141-2. PMID 10780419 |
0.665 |
|
| 1999 |
Shammas MA, Simmons CG, Corey DR, Shmookler Reis RJ. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells Oncogene. 18: 6191-6200. PMID 10597217 DOI: 10.1038/Sj.Onc.1203069 |
0.413 |
|
| 1999 |
Herbert B, Pitts AE, Baker SI, Hamilton SE, Wright WE, Shay JW, Corey DR. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proceedings of the National Academy of Sciences of the United States of America. 96: 14276-81. PMID 10588696 DOI: 10.1073/Pnas.96.25.14276 |
0.336 |
|
| 1999 |
Hamilton SE, Simmons CG, Kathiriya IS, Corey DR. Cellular delivery of peptide nucleic acids and inhibition of human telomerase Chemistry and Biology. 6: 343-351. PMID 10375543 DOI: 10.1016/S1074-5521(99)80046-5 |
0.542 |
|
| 1999 |
Mayfield LD, Corey DR. Enhancing solid phase synthesis by a noncovalent protection strategy - Efficient coupling of rhodamine to resin-bound peptide nucleic acids Bioorganic and Medicinal Chemistry Letters. 9: 1419-1422. PMID 10360748 DOI: 10.1016/S0960-894X(99)00200-0 |
0.302 |
|
| 1999 |
Mayfield LD, Corey DR. Automated synthesis of peptide nucleic acids and peptide nucleic acid- peptide conjugates Analytical Biochemistry. 268: 401-404. PMID 10075832 DOI: 10.1006/Abio.1998.3052 |
0.305 |
|
| 1999 |
Ishihara T, Corey DR. Rules for strand invasion by chemically modified oligonucleotides Journal of the American Chemical Society. 121: 2012-2020. DOI: 10.1021/Ja983834E |
0.715 |
|
| 1998 |
Pitts AE, Corey DR. Inhibition of human telomerase by 2'-O-methyl-RNA. Proceedings of the National Academy of Sciences of the United States of America. 95: 11549-54. PMID 9751703 DOI: 10.1073/Pnas.95.20.11549 |
0.443 |
|
| 1998 |
Coombs GS, Bergstrom RC, Pellequer JL, Baker SI, Navre M, Smith MM, Tainer JA, Madison EL, Corey DR. Substrate specificity of prostate-specific antigen (PSA). Chemistry & Biology. 5: 475-88. PMID 9751643 DOI: 10.1016/S1074-5521(98)90004-7 |
0.705 |
|
| 1998 |
Doyle DF, Corey DR. Engineering proteins: keeping up with biology. Chemistry & Biology. 5: R157-60. PMID 9662511 DOI: 10.1016/S1074-5521(98)90067-9 |
0.577 |
|
| 1998 |
Peet DJ, Doyle DF, Corey DR, Mangelsdorf DJ. Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR. Chemistry & Biology. 5: 13-21. PMID 9479476 DOI: 10.1016/S1074-5521(98)90083-7 |
0.621 |
|
| 1998 |
Coombs GS, Bergstrom RC, Madison EL, Corey DR. Directing sequence-specific proteolysis to new targets. The influence of loop size and target sequence on selective proteolysis by tissue-type plasminogen activator and urokinase-type plasminogen activator. The Journal of Biological Chemistry. 273: 4323-8. PMID 9468480 DOI: 10.1074/Jbc.273.8.4323 |
0.74 |
|
| 1997 |
Hamilton SE, Pitts AE, Katipally RR, Jia X, Rutter JP, Davies BA, Shay JW, Wright WE, Corey DR. Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning. Biochemistry. 36: 11873-80. PMID 9305980 DOI: 10.1021/Bi970438K |
0.475 |
|
| 1997 |
Ke SH, Coombs GS, Tachias K, Corey DR, Madison EL. Optimal subsite occupancy and design of a selective inhibitor of urokinase. The Journal of Biological Chemistry. 272: 20456-62. PMID 9252355 DOI: 10.1074/Jbc.272.33.20456 |
0.744 |
|
| 1997 |
Ke SH, Coombs GS, Tachias K, Navre M, Corey DR, Madison EL. Distinguishing the specificities of closely related proteases. Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase. The Journal of Biological Chemistry. 272: 16603-9. PMID 9195973 DOI: 10.1074/Jbc.272.26.16603 |
0.723 |
|
| 1997 |
Corey DR. Peptide nucleic acids: Expanding the scope of nucleic acid recognition Trends in Biotechnology. 15: 224-229. PMID 9183865 DOI: 10.1016/S0167-7799(97)01037-8 |
0.367 |
|
| 1997 |
Simmons CG, Pitts AE, Mayfield LD, Shay JW, Corey DR. Synthesis and membrane permeability of PNA-peptide conjugates Bioorganic & Medicinal Chemistry Letters. 7: 3001-3006. DOI: 10.1016/S0960-894X(97)10136-6 |
0.315 |
|
| 1997 |
Corey DR, Hamilton S, Simmons C, Mayfield L, Pitts A. 182 Enhanced hybridization by peptide nucleic acids Fibrinolysis and Proteolysis. 11: 52. DOI: 10.1016/S0268-9499(97)80297-4 |
0.322 |
|
| 1997 |
Corey DR, Coombs GS, Bergstrom RC, Madison EL. 178 Targeting proteolysis to non-physiological protein substrates Fibrinolysis and Proteolysis. 11: 51. DOI: 10.1016/S0268-9499(97)80293-7 |
0.723 |
|
| 1996 |
Smulevitch SV, Simmons CG, Norton JC, Wise TW, Corey DR. Enhancement of strand invasion by oligonucleotides through manipulation of backbone charge. Nature Biotechnology. 14: 1700-4. PMID 9634855 DOI: 10.1038/Nbt1296-1700 |
0.801 |
|
| 1996 |
Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR. Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnology. 14: 615-9. PMID 9630953 DOI: 10.1038/Nbt0596-615 |
0.417 |
|
| 1996 |
Hamilton SE, Corey DR. Telomerase: Anti-cancer target or just a fascinating enzyme? Chemistry and Biology. 3: 863-867. PMID 8939712 DOI: 10.1016/S1074-5521(96)90173-8 |
0.314 |
|
| 1996 |
Coombs GS, Dang AT, Madison EL, Corey DR. Distinct mechanisms contribute to stringent substrate specificity of tissue-type plasminogen activator. The Journal of Biological Chemistry. 271: 4461-7. PMID 8626799 DOI: 10.1074/Jbc.271.8.4461 |
0.736 |
|
| 1996 |
Hamilton SE, Iyer M, Norton JC, Corey DR. Specific and nonspecific inhibition of transcription by DNA, PNA, and phosphorothioate promoter analog duplexes Bioorganic and Medicinal Chemistry Letters. 6: 2897-2900. DOI: 10.1016/S0960-894X(96)00538-0 |
0.454 |
|
| 1995 |
Norton JC, Waggenspack JH, Varnum E, Corey DR. Targeting peptide nucleic acid-protein conjugates to structural features within duplex DNA. Bioorganic & Medicinal Chemistry. 3: 437-45. PMID 8581427 DOI: 10.1016/0968-0896(95)00033-D |
0.381 |
|
| 1995 |
Iyer M, Norton JC, Corey DR. Accelerated hybridization of oligonucleotides to duplex DNA. The Journal of Biological Chemistry. 270: 14712-7. PMID 7782335 DOI: 10.1074/Jbc.270.24.14712 |
0.401 |
|
| 1995 |
Corey DR, Munoz-Medellin D, Huang A. Strand invasion by oligonucleotide-nuclease conjugates Bioconjugate Chemistry. 6: 93-100. PMID 7711111 DOI: 10.1021/Bc00031A011 |
0.383 |
|
| 1995 |
Madison EL, Coombs GS, Corey DR. Substrate specificity of tissue type plasminogen activator. Characterization of the fibrin independent specificity of t-PA for plasminogen. The Journal of Biological Chemistry. 270: 7558-62. PMID 7706303 DOI: 10.1074/Jbc.270.13.7558 |
0.718 |
|
| 1995 |
Ding L, Coombs GS, Strandberg L, Navre M, Corey DR, Madison EL. Origins of the specificity of tissue-type plasminogen activator. Proceedings of the National Academy of Sciences of the United States of America. 92: 7627-31. PMID 7644467 DOI: 10.1073/Pnas.92.17.7627 |
0.744 |
|
| 1995 |
Corey DR, Willett WS, Coombs GS, Craik CS. Trypsin specificity increased through substrate-assisted catalysis. Biochemistry. 34: 11521-7. PMID 7547882 DOI: 10.1021/Bi00036A027 |
0.763 |
|
| 1995 |
Coombs GS, Hazzard J, Corey DR. Kinetic characterization of a peptide inhibitor of trypsin isolated from a synthetic peptide combinatorial library Bioorganic and Medicinal Chemistry Letters. 5: 611-614. DOI: 10.1016/0960-894X(95)00082-5 |
0.73 |
|
| 1993 |
Corey DR, Shiau AK, Yang Q, Janowski BA, Craik CS. Trypsin display on the surface of bacteriophage. Gene. 128: 129-34. PMID 8508953 DOI: 10.1016/0378-1119(93)90163-W |
0.512 |
|
| 1992 |
Corey DR, McGrath ME, Vásquez JR, Fletterick RJ, Craik CS. An alternate geometry for the catalytic triad of serine proteases Journal of the American Chemical Society. 114: 4905-4907. DOI: 10.1021/Ja00038A067 |
0.446 |
|
| 1992 |
Corey DR, Craik CS. An investigation into the minimum requirements for peptide hydrolysis by mutation of the catalytic triad of trypsin Journal of the American Chemical Society. 114: 1784-1790. DOI: 10.1021/Ja00031A037 |
0.496 |
|
| 1990 |
Pei D, Corey DR, Schultz PG. Site-specific cleavage of duplex DNA by a semisynthetic nuclease via triple-helix formation. Proceedings of the National Academy of Sciences of the United States of America. 87: 9858-62. PMID 2124705 DOI: 10.1073/Pnas.87.24.9858 |
0.604 |
|
| 1989 |
Corey DR, Schultz PG. Introduction of a metal-dependent regulatory switch into an enzyme. The Journal of Biological Chemistry. 264: 3666-9. PMID 2917969 |
0.392 |
|
| 1989 |
Corey DR, Pei D, Schultz PG. Generation of a catalytic sequence-specific hybrid DNase. Biochemistry. 28: 8277-86. PMID 2605184 DOI: 10.1021/Bi00447A004 |
0.62 |
|
| 1989 |
Corey DR, Pei D, Schultz PG. Sequence-selective hydrolysis of duplex DNA by an oligonucleotide-directed nuclease Journal of the American Chemical Society. 111: 8523-8525. DOI: 10.1021/Ja00204A038 |
0.592 |
|
| 1988 |
Zuckermann RN, Corey DR, Schultz PG. Site-selective cleavage of RNA by a hybrid enzyme Journal of the American Chemical Society. 110: 1614-1615. DOI: 10.1021/Ja00213A040 |
0.691 |
|
| 1987 |
Corey DR, Schultz PG. Generation of a hybrid sequence-specific single-stranded deoxyribonuclease. Science (New York, N.Y.). 238: 1401-3. PMID 3685986 DOI: 10.1126/Science.3685986 |
0.489 |
|
| 1987 |
Zuckermann R, Corey D, Schultz P. Efficient methods for attachment of thiol specific probes to the 3′-ends of synthetic oligodeoxyribonucleotides Nucleic Acids Research. 15: 5305-5321. PMID 3601673 DOI: 10.1093/Nar/15.13.5305 |
0.629 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2004 |
Nulf CJ, Corey DR. Erratum: Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs) (Nucleic Acids Research (2004) vol. 32 (3792-3798)) Nucleic Acids Research. 32. DOI: 10.1093/Nar/Gkh840 |
0.299 |
|
| 1999 |
Pitts AE, Corey DR. The telomerase challenge - an unusual problem in drug discovery. Drug Discovery Today. 4: 155-161. PMID 10322274 DOI: 10.1016/S1359-6446(99)01322-7 |
0.297 |
|
| 2002 |
Corey DR. Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene. 21: 631-7. PMID 11850789 DOI: 10.1038/Sj.Onc.1205063 |
0.296 |
|
| 1994 |
Corey DR, Phillips MA. Cyclic peptides as proteases: a reevaluation. Proceedings of the National Academy of Sciences of the United States of America. 91: 4106-9. PMID 8183879 DOI: 10.1073/Pnas.91.10.4106 |
0.294 |
|
| 2001 |
Ye S, Cech AL, Belmares R, Bergstrom RC, Tong Y, Corey DR, Kanost MR, Goldsmith EJ. The structure of a Michaelis serpin-protease complex. Nature Structural Biology. 8: 979-83. PMID 11685246 DOI: 10.1038/Nsb1101-979 |
0.293 |
|
| 1995 |
Corey DR. 48000-fold Acceleration of Hybridization by Chemically Modified Oligonucleotides Journal of the American Chemical Society. 117: 9373-9374. DOI: 10.1021/Ja00141A038 |
0.293 |
|
| 2023 |
Hofman CR, Corey DR. Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges. Cell Chemical Biology. PMID 37804835 DOI: 10.1016/j.chembiol.2023.09.005 |
0.285 |
|
| 2018 |
Stoddard BL, Khvorova A, Corey DR, Dynan WS, Fox KR. Editorial: Nucleic Acids Research and Nucleic Acid Therapeutics. Nucleic Acids Research. 46: 1563-1564. PMID 29506274 DOI: 10.1093/Nar/Gky059 |
0.271 |
|
| 2000 |
Corey DR. Telomerase: An unusual target for cytotoxic agents Chemical Research in Toxicology. 13: 957-960. PMID 11080041 DOI: 10.1021/Tx0000872 |
0.27 |
|
| 2009 |
Corey DR. Telomeres and telomerase: from discovery to clinical trials. Chemistry & Biology. 16: 1219-23. PMID 20064431 DOI: 10.1016/J.Chembiol.2009.12.001 |
0.251 |
|
| 1997 |
Ke S, Coobms GS, Tachias K, Navre M, Corey DR, Madison EL. 177 Distinguishing the specificities of closely related proteases: Role of P3 in substrate and inhibitor discrimination between tissue type plasminogen activator and urokinase Fibrinolysis and Proteolysis. 11: 51. DOI: 10.1016/S0268-9499(97)80292-5 |
0.25 |
|
| 1985 |
Zucker-Franklin D, Nabi ZF, Corey EJ, Corey DR. A substrate analog inhibitor for arylsulfatase reduces NK cell cytotoxicity Biochemical and Biophysical Research Communications. 126: 540-543. PMID 3970705 DOI: 10.1016/0006-291X(85)90639-4 |
0.241 |
|
| 2016 |
Corey DR. Doubts About Therapy for Neurological Diseases With Antisense Oligonucleotides-Reply. Jama Neurology. PMID 27802484 DOI: 10.1001/Jamaneurol.2016.4335 |
0.238 |
|
| 2010 |
Li Y, Malaeb BS, Li ZZ, Thompson MG, Chen Z, Corey DR, Hsieh JT, Shay JW, Koeneman KS. Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer. The Prostate. 70: 616-29. PMID 20043297 DOI: 10.1002/Pros.21096 |
0.236 |
|
| 2014 |
Corey DR, Wise JA, Fox KR, Stoddard BL. Breakthrough articles: putting science first. Nucleic Acids Research. 42: 11273-4. PMID 25301802 DOI: 10.1093/Nar/Gku853 |
0.233 |
|
| 2002 |
Corey DR. Erratum: Telomerase inhibition, oligonucleotides, and clinical trials Oncogene. 21: 6557-6557. DOI: 10.1038/Sj.Onc.1205721 |
0.23 |
|
| 1985 |
Corey EJ, Cashman JR, Eckrich TM, Corey DR. A new class of irreversible inhibitors of leukotriene biosynthesis Journal of the American Chemical Society. 107: 713-715. DOI: 10.1021/Ja00289A039 |
0.229 |
|
| 1985 |
COREY EJ, CASHMAN JR, ECKRICH TM, COREY DR. ChemInform Abstract: A NEW CLASS OF IRREVERSIBLE INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS Chemischer Informationsdienst. 16. DOI: 10.1002/Chin.198524149 |
0.228 |
|
| 2017 |
Corey DR. Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. Nature Neuroscience. PMID 28192393 DOI: 10.1038/Nn.4508 |
0.222 |
|
| 2005 |
Li Y, Thompson M, Chen Z, Malaeb BS, Corey D, Shay J, Koeneman KS. 463: Telomerase Inhibition Prevents Androgen Independent Osseous Prostate Cancer Progression Journal of Urology. 173: 126-127. DOI: 10.1016/S0022-5347(18)34716-5 |
0.211 |
|
| 2020 |
Aartsma-Rus A, Corey DR. The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. PMID 32043902 DOI: 10.1089/Nat.2020.0845 |
0.201 |
|
| 2003 |
Chen Z, Koeneman KS, Corey DR. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells. Cancer Research. 63: 5917-25. PMID 14522918 |
0.194 |
|
| 1996 |
Corey DR. Not just circus tricks anymore Trends in Biotechnology. 14: 486-487. DOI: 10.1016/S0167-7799(96)89428-5 |
0.177 |
|
| 2022 |
Kilikevicius A, Meister G, Corey DR. Reexamining assumptions about miRNA-guided gene silencing. Nucleic Acids Research. 50: 617-634. PMID 34967419 DOI: 10.1093/nar/gkab1256 |
0.169 |
|
| 2003 |
Liu XZ, Ouyang XM, Xia XJ, Zheng J, Pandya A, Li F, Du LL, Welch KO, Petit C, Smith RJ, Webb BT, Yan D, Arnos KS, Corey D, Dallos P, et al. Prestin, a cochlear motor protein, is defective in non-syndromic hearing loss. Human Molecular Genetics. 12: 1155-62. PMID 12719379 DOI: 10.1093/Hmg/Ddg127 |
0.167 |
|
| 2006 |
Corey DR. EuroTIDES 2005--Sixth Annual IBC Conference. Oligonucleotide, RNAi and peptides for the drug development and manufacturing industry. Idrugs : the Investigational Drugs Journal. 9: 105-6. PMID 16523398 |
0.13 |
|
| 2023 |
Belgrad J, Fakih HH, Johnson KC, Corey DR. Editorial: Nucleic Acids Research virtual issue dedicated to nucleic acid therapeutics, 2018-2023. Nucleic Acids Research. PMID 38035373 DOI: 10.1093/nar/gkad1148 |
0.126 |
|
| 2003 |
Corey D. Sensory transduction in the ear. Journal of Cell Science. 116: 1-3. PMID 12456710 DOI: 10.1242/JCS.00101 |
0.022 |
|
| 2010 |
Bosy D, Etlin D, Corey D, Lee JW. An interdisciplinary pain rehabilitation programme: description and evaluation of outcomes. Physiotherapy Canada. PhysiothéRapie Canada. 62: 316-26. PMID 21886371 DOI: 10.3138/physio.62.4.316 |
0.012 |
|
| Hide low-probability matches. |
